Baird Medical Investment Holdings Limited Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $22.5M-39.2% YoYTTM through 31 Dec 2025
Net Income -$27.3M-319.0% YoYTTM through 31 Dec 2025
Free Cash Flow -$1.4MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 83.8% |
| EBITDA Margin | -108.8% |
| Operating Margin | -113.6% |
| Net Margin | -121.0% |
Returns
-87.4%ROE
-39.1%ROA
Balance Sheet Health
Debt / Equity0.61x
Current Ratio1.70x
Net Debt$18.7M
Cash & Equivalents$178.3K
Quality Metrics
Altman Z-Score-0.12
Piotroski F-Score1 / 9
FCF Margin-6.2%
Multi-Year Trend
RevenueFY2025: $22.5M
Diluted EPS-$0.98TTMFY2025: $-0.98
Dividend
No dividend
Capital Allocation
R&D Spend$20.1M
Capex Intensity0.2%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Direct Customers | $4.1M | -79.3% | |
| Distributors | $18.4M | +7.0% |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.